Hide Board Information

Show Board Information

CNS Pharmaceuticals Inc. CNSP

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/18/2024 4:15:33 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 30

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Stock Message Board

1. CNSP Company Profile

    

2. CNSP Time & Sales

    

3. CNSP Recent News

    

4. CNSP Filings

    

5. CNSP Financials

    

6. CNSP Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

175	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	01/12/2023 3:14:49 PM
174	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	01/09/2023 2:55:51 PM
173	Four Developments in Cancer Research That	NetworkNewsWire	01/05/2023 4:35:16 PM
172	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	01/05/2023 3:37:16 PM
171	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	01/03/2023 4:13:59 PM
170	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	12/28/2022 5:41:55 PM
169	Machine Learning Effort Enables Large-Scale	NetworkNewsWire	12/27/2022 5:09:50 PM
168	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides	NetworkNewsWire	12/22/2022 4:46:22 PM
167	New Study Finds Localized Cooling of Brain Tumors	NetworkNewsWire	12/19/2022 4:57:02 PM
166	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Anchors	NetworkNewsWire	12/14/2022 4:31:02 PM
165	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	12/14/2022 4:07:28 PM
164	Data Shows Increase in Mortality Among Patients	NetworkNewsWire	12/12/2022 5:22:44 PM
163	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Has	NetworkNewsWire	12/12/2022 3:40:38 PM
162	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	12/08/2022 2:49:14 PM
161	Research Recommends Reduction of Pediatric Brain	NetworkNewsWire	12/05/2022 5:15:37 PM
160	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	12/05/2022 4:46:55 PM
159	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	12/01/2022 3:56:42 PM
158	Four Facts You Need to Know About Brain Cancer	NetworkNewsWire	11/29/2022 4:57:23 PM
157	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/29/2022 4:30:32 PM
156	European Clinical Trial Site Expansion for CNS	NetworkNewsWire	11/28/2022 3:46:18 PM
155	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/23/2022 4:23:53 PM
154	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	11/22/2022 4:03:45 PM
153	Implanted Pump Holds Promise in Treating Brain	NetworkNewsWire	11/21/2022 4:35:49 PM
152	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO	NetworkNewsWire	11/16/2022 3:58:17 PM
151	Researchers Turn to AI for Insights on Treating	NetworkNewsWire	11/15/2022 4:34:35 PM
150	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/15/2022 3:21:43 PM
149	Scientists Look for Ways to Disable Sugar	NetworkNewsWire	11/14/2022 5:13:04 PM
148	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	11/14/2022 3:40:27 PM
147	Research Finds New Therapy Path for Brain Cancer	NetworkNewsWire	11/10/2022 5:09:02 PM
146	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	11/10/2022 5:02:02 PM
145	New Brain Cancer Clinical Trial Platform Launched	NetworkNewsWire	11/07/2022 5:37:39 PM
144	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	11/07/2022 5:09:27 PM
143	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/02/2022 4:38:08 PM
142	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	10/31/2022 4:48:21 PM
141	Researchers Discover New Way to Noninvasively	NetworkNewsWire	10/27/2022 5:04:45 PM
140	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/17/2022 4:04:25 PM
139	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/14/2022 3:59:13 PM
138	Researchers Uncover Vital Clues on Drivers Behind	NetworkNewsWire	10/13/2022 5:04:53 PM
137	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/10/2022 4:54:27 PM
136	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	10/07/2022 5:53:40 PM
135	New Laws on Abortion May Complicate Cancer	NetworkNewsWire	10/06/2022 5:24:11 PM
134	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/03/2022 4:51:48 PM
133	UC San Diego Offers New Radiation Therapy That	NetworkNewsWire	09/30/2022 4:31:13 PM
132	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/28/2022 3:52:18 PM
131	Study Finds That Endometriosis Prognosis Worsens	NetworkNewsWire	09/23/2022 6:43:34 PM
130	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/23/2022 6:16:14 PM
129	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	09/19/2022 4:21:37 PM
128	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/16/2022 3:54:35 PM
127	Focused Ultrasound May Offer Easier Way to Treat	NetworkNewsWire	09/15/2022 5:24:01 PM
126	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Takes	NetworkNewsWire	09/13/2022 4:17:09 PM

Newer

Older

Recent Articles

• Future of Rosacea Treatment Market Worth USD 3.16 Billion by 2031
• Reddit's Stake Sale Raises Questions Amid Market Volatility
• Sharp Decline in Euro Zone Business Activity Signals Challenges Ahead
• Capitalize Launches Innovative Trading Program for Aspiring Traders
• Globaltrans Transitions to New Trading Venue for GDRs
• Xtrackers Enhances DAX ETF with New ESG Criteria
• Record-Breaking Inflows Projected for US Equity Funds in 2024
• Meta's Strategic Battle Against $64 Billion Scams on Dating Apps
• Hyundai's New CEO Foresees Growth in the EV Sector Amid Changes
• Sunlands Technology Group's Q3 2024 Results Showcase Growth Potential
• German Industry Faces Continued Decline in Production for 2024
• Nvidia's Stock Ratings Shift: What It Means for Investors
• Northvolt's Strategic Shift: Leadership Change Amid Bankruptcy
• Market Movements: Bitcoin Surges and Economic Woes in Europe
• Market Volatility Predicted as Trump Takes Office: Barclays Insight
• Germany's Business Activity Faces Deeper Decline in November
• Garanti BBVA Launches $750M Subordinated Notes for Growth
• South32 Enhances Share Buy-Back Program for Market Confidence
• Ondine Biomedical Directors Increase Stake After Fundraising
• ECB's Lagarde Advocates for Stronger Economic Unity in Europe
• European Markets Show Resilience Amidst Rising Geopolitical Tensions
• European Markets Rally on Tech Sector Surge and Optimism
• Indonesia Stock Market Sees Gains as IDX Composite Climbs
• Zircuit Unveils ZRC Token: A New Chapter in Finance Innovation
• Anticipated Earnings Report Highlights for Investors
• Global Collaboration Essential for Climate Deal at COP29 Summit
• Frontier IP Group Launches Share Subscription at 28p Each
• Navigating Market Trends: Insights on Global Dynamics
• Gold and Bitcoin Surge Amid Global Economic Changes
• Huawei's Mate 70 Series Set to Challenge Apple in Smartphone Market
• French Economic Activity Declines Sharply Amid New Order Drop
• Gautam Adani's U.S. Indictment: Implications for His Empire
• Understanding US Ballistic Missile Launch Detection Systems
• mLean Celebrates a Decade of Transforming Manufacturing
• Amundi Gold ETC Expands with New Securities Tranche Announcement
• Amundi Physical Gold ETC Expands with New Tranche Launch
• Bitcoin Reaches New Heights, Eyes the $100K Milestone
• Exploring Adani Group's Global Presence in Major Projects
• UBS Projects Negative Trends in Emerging Markets by 2025
• Geopolitical Tensions Fuel Surge in Oil and Gas Prices
• NVIDIA's Potential Growth: Analysts Predict Price Surge Ahead
• Huawei Mate 70 Smartphone to Challenge Apple with New Chips
• Projections for the Expanding Gene Panel Market's Future
• Neometals Champions Battery Recycling During Market Challenges
• Texas Governor Takes Action Against Chinese Investments for Security
• German Housing Market Set for Recovery with Rising Prices
• Impact of Trump's DOGE on Federal Budget Projections
• Leadership Transition at Jyske Realkredit Marks New Beginnings
• Centamin PLC Faces Temporary Trading Suspension on LSE
• Leadership Transition at Jyske Realkredit: A New Era Ahead